Patient safety set to gain from new partnership between CDISC and UMC

Communications / 20 February 2024

The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.


A new collaboration between two leading organisations in global medical data has been announced to bring greater efficiency and certainty to regulatory bodies, industry, and the healthcare community, ultimately aiming to improve patient safety worldwide.

Historically, lack of interoperability has been a significant stumbling block to the effective sharing and use of medicinal product safety data. The strategic partnership announced today takes aim at the problem, combining the expertise of the Clinical Data Interchange Standards Consortium (CDISC) in clinical data standards with that of Uppsala Monitoring Centre (UMC) as the developer of WHODrug Global, the world most widely used drug dictionary.

Together, CDISC and UMC will work to strengthen interoperability between CDISC standards and WHODrug Global for the benefit of users, regulatory bodies, and the broader healthcare community.

 

Chris Decker, CEO and president of CDISC

Chris Decker, CEO and president of CDISC

“CDISC is excited to expand our long collaboration with Uppsala Monitoring Centre to support the global community in connecting WHODrug Global with CDISC’s Study Data Tabulation Model.”

“CDISC is excited to expand our long collaboration with Uppsala Monitoring Centre to support the global community in connecting WHODrug Global with CDISC’s Study Data Tabulation Model,” said Chris Decker, President and CEO, CDISC.

“CDISC has been an important collaborator for many years. Formalizing our collaboration is a natural next step. We believe that it is critical that standard-developing organizations related to each other should unite and collaborate actively, and we are very happy to do this together with CDISC. True interoperability is paramount to empower global healthcare initiatives and ensure the seamless utilisation of data among regulators and across the industry," said Peter Hjelmström, Director, Uppsala Monitoring Centre.

The collaboration will take the form of knowledge sharing, networking, and joint projects, and the partners will deliver training and presentations for their respective user groups, focusing on standards, best practice implementation, and interoperability. Furthermore, the two organizations will engage in continuous information sharing and will also oversee and review technical documentation related to CDISC standards and WHODrug Global, to ensure comprehensive understanding and alignment. CDISC and UMC will also promote and encourage participation in each other's user group events, conferences, and workshops.

CDISC is a global leader in clinical data standards for regulatory submissions, while UMC is recognised for its operational support to the WHO Programme for International Drug Monitoring and pharmacovigilance initiatives to advance the safety of medicines and vaccines globally.

 

About CDISC

Clinical Data Interchange Standards Consortium (CDISC) is a global non-profit organisation that develops and advances data standards of the highest quality to transform incompatible formats, inconsistent methodologies, and diverse perspectives into a robust framework for generating accessible clinical research data. Driven by the belief that the true measure of data is its impact, CDISC convenes a global community of research experts representing a range of experiences and backgrounds to harness the collective power to drive more meaningful clinical research.

 

READ MORE:

Learn more about CDISC

You may also like


Catching Black swans – New podcast out now

We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.

Communications / 04 March 2024

When drugs damage the liver– New podcast out now

The liver, responsible for drug metabolism in the body, is also most at risk of damage due to medicines. Unravel the complexities of DILI and its impact on medication safety.

Communications / 05 February 2024

Fifty years of putting medicines and vaccine safety at the heart of global healthcare

The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.

Communications / 11 March 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more